Kindred Biosciences, Inc. (KIN)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
13-Sep-21 4:30 PM
View: 
Park West Asset Management ...
10% Owner
Kindred Biosciences, Inc. (KIN) 27-Aug-21Disposition (other) 6,000,000----(100%)
6.0M to 0
30-Aug-21 3:45 PM
View: 
Townsend Raymond
Director
Kindred Biosciences, Inc. (KIN) 27-Aug-21Disposition 24,928$9.25$230,584.00(100%)
24.93K to 0
0%
30-Aug-21 9:46 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 27-Aug-21Disposition 1,709,270$9.25$15,810,800.00(100%)
1.72M to 8.0K
0%
30-Aug-21 5:17 PM
View: 
Zhan Hangjun
Chief Scientific Officer
Kindred Biosciences, Inc. (KIN) 27-Aug-21Disposition 64,306$9.25$594,830.00(100%)
64.31K to 0
0%
30-Aug-21 5:43 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 27-Aug-21Disposition 145,835$9.25$1,348,970.00(100%)
145.84K to 0
0%
30-Aug-21 6:08 PM
View: 
Wee Wendy
Chief Financial Officer
Kindred Biosciences, Inc. (KIN) 27-Aug-21Disposition 78,613$9.25$727,170.00(100%)
78.61K to 0
0%
30-Aug-21 9:46 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 27-Aug-21Disposition 8,000$9.25$74,000.00(100%)
8.0K to 0
0%
04-Aug-21 3:00 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 02-Aug-21Market Sale (Planned) 40,000$9.21$368,240.00(3%)
1.57M to 1.53M
(< 1%)
04-Aug-21 3:00 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 22-Jul-21Gift 320,000----(17%)
1.89M to 1.57M
07-Jul-21 12:02 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 02-Jul-21Market Sale (Planned) 40,000$9.18$367,080.00(2%)
1.93M to 1.89M
(< 1%)
17-Jun-21 9:30 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 16-Jun-21Market Sale (Planned) 40,000$9.18$367,268.00(2%)
1.97M to 1.93M
(< 1%)
07-Jun-21 6:58 PM
View: 
Park West Asset Management ...
10% Owner
Kindred Biosciences, Inc. (KIN) 04-Jun-21Market Sale 345,383$6.95$2,400,580.00(5%)
6.35M to 6.0M
(33%)
07-Jun-21 6:58 PM
View: 
Park West Asset Management ...
10% Owner
Kindred Biosciences, Inc. (KIN) 03-Jun-21Market Sale 69,600$6.80$473,092.00(1%)
6.41M to 6.35M
(36%)
18-Mar-21 4:35 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 17-Mar-21Option Exercise 8,396$0.32$2,686.726%
143.84K to 152.23K
18-Mar-21 4:35 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 17-Mar-21Market Option Sale (Planned) 8,396$5.00$41,996.80(6%)
152.23K to 143.84K
(85%)
23-Feb-21 4:55 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 22-Feb-21Option Exercise 4,622$0.32$1,479.043%
143.84K to 148.46K
23-Feb-21 4:55 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 22-Feb-21Market Option Sale (Planned) 4,622$5.00$23,110.00(3%)
148.46K to 143.84K
(85%)
23-Feb-21 4:55 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 19-Feb-21Option Exercise 5$0.32$1.60< 1%
143.84K to 143.84K
23-Feb-21 4:55 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 19-Feb-21Market Option Sale (Planned) 5$5.00$25.00(< 1%)
143.84K to 143.84K
(85%)
03-Feb-21 3:20 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 01-Feb-21Option Exercise 12,500----< 1%
1.97M to 1.98M
03-Feb-21 3:20 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 01-Feb-21Payment of Exercise 6,582$5.00$32,910.00(< 1%)
1.98M to 1.97M
(85%)
01-Feb-21 6:00 PM
View: 
Park West Asset Management ...
10% Owner
Kindred Biosciences, Inc. (KIN) 29-Jan-21Market Sale 3,300$5.07$16,731.00(< 1%)
6.42M to 6.41M
(82%)
01-Feb-21 6:00 PM
View: 
Park West Asset Management ...
10% Owner
Kindred Biosciences, Inc. (KIN) 28-Jan-21Market Sale 210,472$5.25$1,104,980.00(3%)
6.63M to 6.42M
(76%)
26-Jan-21 8:50 PM
View: 
Zhan Hangjun
Chief Scientific Officer
Kindred Biosciences, Inc. (KIN) 23-Jan-21Payment of Exercise 3,385$4.93$16,688.00(8%)
42.69K to 39.31K
(87%)
26-Jan-21 9:06 PM
View: 
Wee Wendy
Chief Financial Officer
Kindred Biosciences, Inc. (KIN) 23-Jan-21Payment of Exercise 3,385$4.93$16,688.00(6%)
52.42K to 49.04K
(87%)
26-Jan-21 8:36 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 23-Jan-21Payment of Exercise 13,163$4.93$64,893.60(< 1%)
1.98M to 1.97M
(87%)
26-Jan-21 8:36 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 22-Jan-21Option Exercise 37,500----2%
1.96M to 2.0M
26-Jan-21 8:50 PM
View: 
Zhan Hangjun
Chief Scientific Officer
Kindred Biosciences, Inc. (KIN) 22-Jan-21Option Exercise 6,250----16%
39.83K to 46.08K
26-Jan-21 9:06 PM
View: 
Wee Wendy
Chief Financial Officer
Kindred Biosciences, Inc. (KIN) 22-Jan-21Option Exercise 7,500----15%
48.99K to 56.49K
26-Jan-21 8:50 PM
View: 
Zhan Hangjun
Chief Scientific Officer
Kindred Biosciences, Inc. (KIN) 22-Jan-21Payment of Exercise 3,385$4.93$16,688.00(7%)
46.08K to 42.69K
(87%)
26-Jan-21 9:06 PM
View: 
Wee Wendy
Chief Financial Officer
Kindred Biosciences, Inc. (KIN) 22-Jan-21Payment of Exercise 4,062$4.93$20,025.70(7%)
56.49K to 52.42K
(87%)
26-Jan-21 8:36 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 22-Jan-21Payment of Exercise 19,744$4.93$97,337.90(< 1%)
2.0M to 1.98M
(87%)
20-Jan-21 6:58 PM
View: 
Zhan Hangjun
Chief Scientific Officer
Kindred Biosciences, Inc. (KIN) 17-Jan-21Option Exercise 6,250----17%
36.96K to 43.21K
20-Jan-21 7:11 PM
View: 
Wee Wendy
Chief Financial Officer
Kindred Biosciences, Inc. (KIN) 17-Jan-21Option Exercise 6,250----14%
46.1K to 52.35K
20-Jan-21 6:58 PM
View: 
Zhan Hangjun
Chief Scientific Officer
Kindred Biosciences, Inc. (KIN) 17-Jan-21Payment of Exercise 3,385$4.95$16,755.80(8%)
43.21K to 39.83K
(87%)
20-Jan-21 7:11 PM
View: 
Wee Wendy
Chief Financial Officer
Kindred Biosciences, Inc. (KIN) 17-Jan-21Payment of Exercise 3,385$4.95$16,755.80(6%)
52.35K to 48.97K
(87%)
20-Jan-21 7:20 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 17-Jan-21Payment of Exercise 21,128$4.95$104,584.00(1%)
1.98M to 1.96M
(87%)
20-Jan-21 7:20 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 17-Jan-21Option Exercise 37,500----2%
1.95M to 1.98M
15-Jan-21 6:27 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 14-Jan-21Option Exercise 13,023$0.32$4,167.369%
143.84K to 156.86K
15-Jan-21 6:27 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 14-Jan-21Market Option Sale (Planned) 13,023$5.00$65,115.00(8%)
156.86K to 143.84K
(85%)
08-Jan-21 7:03 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 07-Jan-21Market Option Sale 39,069$5.00$195,349.00(21%)
182.9K to 143.84K
(85%)
08-Jan-21 7:03 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 07-Jan-21Option Exercise 39,069$0.32$12,502.1027%
143.84K to 182.9K
08-Oct-20 9:11 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 07-Oct-20Option Exercise 12,508$0.32$4,002.569%
143.84K to 156.34K
08-Oct-20 9:11 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 07-Oct-20Market Option Sale 12,508$5.01$62,627.60(8%)
156.34K to 143.84K
(84%)
24-Sep-20 6:45 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 22-Sep-20Option Exercise 515$0.32$164.80< 1%
143.84K to 144.35K
24-Sep-20 6:45 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 22-Sep-20Market Option Sale 515$5.00$2,575.00(< 1%)
144.35K to 143.84K
(84%)
03-Aug-20 8:46 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 31-Jul-20Payment of Exercise 59,498$3.29$195,748.00(29%)
203.33K to 143.84K
(180%)
03-Aug-20 8:46 PM
View: 
Bevers Denise
Director
Kindred Biosciences, Inc. (KIN) 31-Jul-20Option Exercise 95,000----88%
108.33K to 203.33K
30-Jun-20 9:30 PM
View: 
Park West Asset Management ...
10% Owner
Kindred Biosciences, Inc. (KIN) 26-Jun-20Market Sale 115,136$4.71$542,291.00(2%)
6.74M to 6.63M
(96%)
13-Feb-20 4:28 PM
View: 
Chin Richard
Chief Executive Officer
Director
Kindred Biosciences, Inc. (KIN) 11-Feb-20Payment of Exercise 4,317$9.22$39,802.70(< 1%)
1.95M to 1.95M
< 1%